[Synergistic inhibitory effect of STI571 in combination with arsenic trioxide on a multidrug-resistant leukemia cell line expressing bcr-abl]. [electronic resource]
Producer: 20060317Description: 535-8 p. digitalISSN:- 0253-3766
- Antineoplastic Agents -- pharmacology
- Arsenic Trioxide
- Arsenicals -- pharmacology
- Benzamides
- Cell Survival -- drug effects
- Drug Resistance, Multiple
- Drug Resistance, Neoplasm
- Drug Synergism
- Genes, MDR
- Genes, abl
- Humans
- Imatinib Mesylate
- Inhibitory Concentration 50
- K562 Cells
- Oxides -- pharmacology
- Piperazines -- pharmacology
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrimidines -- pharmacology
- Vincristine -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.